±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1753  |  »Ø¸´: 7
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

³Ôɶ×Ó³Ô°¡

гæ (³õÈëÎÄ̳)

[ÇóÖú] ÇóάÀ­×ôͪ£¨Vilazodone£©ÔÓÖʵÄÎÄÏ×±¨µÀ

Ò©Æ·»ù±¾ÐÅÏ¢ÈçÏ£º
¡¡ÖÐÎÄÃû³Æ£ºÎ¬À­×ôͪ
  Ó¢ÎÄÃû³Æ Vilazodone ¡¡¡¡
  Ó¢ÎıðÃû 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-    carboxamide ¡¡¡¡
  CAS NO. 163521-12-8
   2011Äê1ÔÂ21ÈÕÅú×¼ÑÎËáάÀ­×ôͪ£¨ÉÌÆ·ÃûViibryd£©Æ¬¼ÁÓÃÓÚÖÎÁƳÉÈËÖØ¶ÈÒÖÓôÖ¢¡£
  ÇóÖú¸ÃÒ©µÄÔÓÖʱ¨µÀµÄÎÄÏ×»òÕßרÀû£¡Ð»Ð»!
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ÕÒÄ×ÓÆ¤

°æÖ÷ (ÎÄ̳¾«Ó¢)

ÀÏÆ¦

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

ÒýÓûØÌû:
5Â¥: Originally posted by ³Ôɶ×Ó³Ô°¡ at 2012-06-15 10:53:24
Á´½Ó´ò²»¿ª°¡ ÕâÆªÎÄÏ×ÎÒÓÐµÄ ÉÏÃæºÃÏñÖ»±¨µÀÁËһЩ´úл²úÎ²¢Ã»ÓÐÃ÷È·µÄÔÓÖʱ¨µÀ£¡
   ÇóÏê½â£¡Ð»Ð»£¡...

ÊÔÊÔÕÒÒ»ÏÂÕâÁ½¸öרÀûUS5532241¡¢US7834020£¬¿ÉÄÜÉæ¼°Ïà¹ØÔÓÖʵÄÐÅÏ¢¡£
ÊØºòÔÚ·çÖеÄÄþ¾²¡£
6Â¥2012-06-15 11:09:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 8 ¸ö»Ø´ð

wojiushiyao

ľ³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mouse103: ½ð±Ò+1, лл²ÎÓë 2012-06-15 22:36:42
CENTER FOR DRUG EVALUATION AND RESEARCH
APPLICATION NUMBER:
022567Orig1s000
2Â¥2012-06-12 16:54:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³Ôɶ×Ó³Ô°¡

гæ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by wojiushiyao at 2012-06-12 16:54:39
CENTER FOR DRUG EVALUATION AND RESEARCH
APPLICATION NUMBER:
022567Orig1s000

ÄÜ˵ÏêϸµãÂð~лл£¡
3Â¥2012-06-13 10:03:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wojiushiyao

ľ³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
³Ôɶ×Ó³Ô°¡: ½ð±Ò+6, ¡ï¡ï¡ïºÜÓаïÖú 2012-06-18 13:35:51
www.accessdata.fda.gov/.../022567Orig1s000SumR.pdf

M E M O R A N D U M DEPARTMENT OF HEALTH AND HUMAN SERVICES
PUBLIC HEALTH SERVICE
FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH
DATE: January 18, 2011
FROM: Thomas P. Laughren, M.D.
Director, Division of Psychiatry Products
HFD-130
SUBJECT: Recommendation for approval action for vilazodone tablets as a treatment for
major depressive disorder (MDD).
TO: File NDA 22-567
[Note: This overview should be filed with the 3-22-10 original submission of this
NDA.]
4Â¥2012-06-13 14:22:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 289Çóµ÷¼Á +5 BrightLL 2026-03-29 5/250 2026-03-29 17:24 by zhyzzh
[¿¼ÑÐ] 343Çóµ÷¼Á +6 °®î¿°í 2026-03-29 6/300 2026-03-29 12:00 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 085600£¬×¨Òµ¿Î»¯¹¤Ô­Àí£¬321·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-03-28 5/250 2026-03-29 08:56 by qingfeng258
[¿¼ÑÐ] 0703 »¯Ñ§ Çóµ÷¼Á£¬Ò»Ö¾Ô¸É½¶«´óѧ 342 ·Ö +4 Shern¡ª- 2026-03-28 4/200 2026-03-29 00:47 by 544594351
[¿¼ÑÐ] 311£¨085601£©Çóµ÷¼Á +4 liziyeyeye 2026-03-28 4/200 2026-03-28 18:50 by 535743368
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª±±µçÁ¦´óѧÄܶ¯×¨Ë¶£¬293£¬Çóµ÷¼Á +3 15537177284 2026-03-23 5/250 2026-03-28 16:11 by xxxsssccc
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +7 hanamiko 2026-03-27 7/350 2026-03-28 09:56 by ÀîÉϰ¶0921
[¿¼ÑÐ] 265Çóµ÷¼Á11408 +3 ÁõС¹lu 2026-03-27 3/150 2026-03-27 20:53 by nihaoar
[¿¼ÑÐ] 266Çóµ÷¼Á +11 ÑôÑôÍÛÈû 2026-03-27 12/600 2026-03-27 17:56 by yu221
[¿¼ÑÐ] 266·ÖÇó²ÄÁÏ»¯¹¤Ò±½ð¿óÒµµÈרҵµÄµ÷¼Á +4 ÍÛºôºßºôºß 2026-03-26 4/200 2026-03-27 17:02 by zhyzzh
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á +4 RipcordÉϰ¶ 2026-03-27 4/200 2026-03-27 17:00 by zhyzzh
[¿¼ÑÐ] 287Çóµ÷¼Á +10 land xuxu 2026-03-26 10/500 2026-03-27 15:33 by ÅÁ¶ûÂíÀ­ÌØ
[¿¼ÑÐ] °²»Õ´óѧר˶ÉúÎïÓëҽҩרҵ(086000)324·Ö£¬Ó¢ÓïÒѹýËÄÁù¼¶£¬Áù¼¶521£¬Çóµ÷¼Á +4 ÃÀζ¿ÉÀÖ¼¦³á 2026-03-26 4/200 2026-03-27 15:27 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +8 Æ¥¿Ëi 2026-03-23 8/400 2026-03-27 08:11 by hypershenger
[¿¼ÑÐ] ²ÄÁÏ¿¼ÑÐÇóµ÷¼Á +3 Dendel 2026-03-23 6/300 2026-03-26 17:51 by fmesaito
[¿¼ÑÐ] 085602 289·ÖÇóµ÷¼Á +8 WWWÎ÷Î÷¸¥Ë¹ 2026-03-24 8/400 2026-03-26 16:33 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 332Çóµ÷¼Á +6 032500 2026-03-25 6/300 2026-03-25 22:45 by 418490947
[¿¼ÑÐ] 285Çóµ÷¼Á +3 AZMK 2026-03-24 3/150 2026-03-25 12:23 by userper
[¿¼ÑÐ] 086003ʳƷ¹¤³ÌÇóµ÷¼Á +6 íµíµ111 2026-03-24 6/300 2026-03-25 10:29 by 3Strings
[¿¼ÑÐ] ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£© +4 ÎÒ°®Ñ§µç³Ø 2026-03-23 4/200 2026-03-25 00:59 by 1027_324
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û